Paraquat Poisoning: Current Advances in Pathophysiology, Diagnostic Biomarkers, and Evidence-Based Management Protocols
SAP Health and Policy · 26.07.2026 · 5 · 320
DOI: 10.62486/shp2026320 ↗Kurz gefasst
Fachartikel in der Zeitschrift SAP Health and Policy, online erschienen am 26.07.2026. Verfasst von Omatighene E.O und 6 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Paraquat (1,1′-dimethyl-4,4′-bipyridinium dichloride), a widely used herbicide with high human lethality due to its redox cycling, generating reactive oxygen species that induce irreversible multi-organ failure and pulmonary fibrosis. Despite known mechanisms, clinical management remains challenging and mortality exceeds 60%. This systematic review synthesizes global evidence on paraquat toxicity mechanisms, prognostic biomarkers, therapeutic interventions, and public health policies to guide clinical practice and regulatory decision-making.
Methods
Following PRISMA guidelines, PubMed, MEDLINE, Embase, Scopus, Web of Science, and WHO IRIS were searched till January 2026. Studies on pathophysiology, diagnostics, treatments, and policy were narratively evaluated.
Results
From 1,842 identified studies, 39 met inclusion criteria. Pathophysiologically, cellular uptake via polyamine transporters drives mitochondrial electron leakage, p38 MAPK/NF-κB inflammatory signaling, and TGF-β-mediated interstitial fibrosis. While plasma nomograms and lactate levels reliably predict mortality, targeted therapies show variable success. Randomized controlled trial evidence refutes high-dose immunosuppression benefits, whereas early hemoperfusion (under 4 hours) and restrictive oxygen therapy demonstrate clinical utility. Public health bans in Sri Lanka, South Korea, and Taiwan yielded a 40–50% reduction in pesticide suicides without harming agricultural yields.
Conclusion
Prognostic biomarkers accurately identify severe exposures, yet proven clinical treatments remain limited beyond early extracorporeal clearance and restrictive oxygenation. National regulatory restriction stands as the single most effective, evidence-based intervention to prevent paraquat-related fatalities worldwide.
Zitieren
APA
E.O, O., O, U., E, E. O., B, O. A., M, E. I., I, I., & J, O. O. (2026). Paraquat Poisoning: Current Advances in Pathophysiology, Diagnostic Biomarkers, and Evidence-Based Management Protocols. SAP Health and Policy, 5, 320. https://doi.org/10.62486/shp2026320
Vancouver
E.O O, O U, E EO, B OA, M EI, I I, et al. Paraquat Poisoning: Current Advances in Pathophysiology, Diagnostic Biomarkers, and Evidence-Based Management Protocols. SAP Health and Policy. 2026;5:320. doi:10.62486/shp2026320
BibTeX
@article{EO2026,
author = {E.O, Omatighene and O, Ukoba and E, Emuoghenerue O. and B, Odonmeta A. and M, Enemuwe I. and I, Iboyitie and J, Obodo O.},
title = {Paraquat Poisoning: Current Advances in Pathophysiology, Diagnostic Biomarkers, and Evidence-Based Management Protocols},
journal = {SAP Health and Policy},
year = {2026},
volume = {5},
pages = {320},
doi = {10.62486/shp2026320}
}
EUVIMED